CIK 0001799191
- Accelerated filer
- Smaller reporting company
Starling Oncology, Inc.
Sign in to watch- Tickers
- STLN STLNW DFPH
- Exchange
- Nasdaq, OTC
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 843562323
- Phone
- +1 562-735-3226
- Business address
- 18000 STUDEBAKER RD, SUITE 800, CERRITOS, CA, 90703
- Former names
- Oncology Institute, Inc., DFP HEALTHCARE ACQUISITIONS CORP.
Securities
- STLN Common Stock Nasdaq
- STLNW Common stock Nasdaq
- DFPH Common stock OTC
- 4/A Derivatives Options or other derivatives
- 4 Grant or award Chief Financial Officer acquired 32,092 shares (grant or award)
- 4 Grant or award Director acquired 23,191 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 108,469 shares (grant or award)
- 4 Grant or award Director acquired 19,992 shares (grant or award)
- 4 Grant or award President acquired 42,015 shares (grant or award)
- 4 Grant or award Director acquired 20,792 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 14,884 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 28,027 shares (grant or award)
- 4 Grant or award Director acquired 45,905 shares (grant or award)
- 4 Grant or award Director acquired 22,391 shares (grant or award)
- 4 Grant or award Director acquired 20,792 shares (grant or award)
- 3/A Insider 3/A
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 5,000 shares at an average $6.92 ($34,605)
- 4 Open-market buy Director bought 5,000 shares at an average $6.34 ($31,699)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4/A Grant or award Director acquired 4,109,771 shares (grant or award)
Page 12 of 14 · 270 filings